Intervention not reported
Absence of symptoms at 48 hours ‐ patient assessment
The intervention may leads to higher absence of symptoms at 48 hours ‐ patient assessment (low certainty).
1 finding from 1 review
Time to institutionalisation at 12 months · people with dementia
1 finding from 1 review
Hospital admissions · people with dementia
Case management showed no clear difference in hospital admission (number of participants admitted) at 12 months compared with usual care (moderate certainty).
1 finding from 1 review
Mortality (number of deaths) at 12 months · people with dementia
Case management showed no clear difference in mortality (number of deaths) at 12 months compared with usual care (high certainty).
1 finding from 1 review
Quality of life (participants) at 12 months · people with dementia
Case management showed no clear difference in quality of life (participants) at 12 months compared with usual care (high certainty).
1 finding from 1 review
Carer burden, well‐being or quality of life · people with dementia
Case management probably leads to higher quality of life (carers) at 12 months compared with usual care (moderate certainty).
1 finding from 1 review
Carer burden · people with dementia
Case management showed no clear difference in carer burden at 10 ‐ 12 months compared with usual care (low certainty).
1 finding from 1 review
Maternal anaemia at term or near term (haemoglobin (Hb) less than 110 g/L at 34 weeks' gestation or more) · women during pregnancy
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Adverse effects (any)* · women during pregnancy
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Low birthweight · women during pregnancy
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Preterm birth · women during pregnancy
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Maternal iron deficiency at term or near term (as defined by authors of the trials, based on any indicator of iron status at 34 weeks' gestation or more) · women during pregnancy
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Maternal death · women during pregnancy
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Adverse effects (any)* · women during pregnancy
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Low birthweight · women during pregnancy
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Preterm birth · women during pregnancy
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Maternal anaemia at term or near term (haemoglobin (Hb) less than 110 g/L at 34 weeks' gestation or more) · women during pregnancy
1 finding from 1 review
no estimate extracted
470 participants
Very low
Maternal iron deficiency at term or near term (as defined by authors of the trials, based on any indicator of iron status at 34 weeks' gestation or more) · women during pregnancy
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Maternal death · women during pregnancy
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Intervention not reported
Mortality · patients with COPD
The intervention showed no clear difference in mortality (low certainty).
1 finding from 1 review